Arvee Laboratories (India) Limited (NSE:ARVEE) — Market Cap & Net Worth
Market Cap & Net Worth: Arvee Laboratories (India) Limited (ARVEE)
Arvee Laboratories (India) Limited (NSE:ARVEE) has a market capitalization of $18.68 Million (Rs1.73 Billion) as of August 4, 2026. Listed on the NSE stock exchange, this India-based company holds position #25287 globally and #1402 in its home market, demonstrating a -1.05% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Arvee Laboratories (India) Limited's stock price Rs156.72 by its total outstanding shares 11020000 (11.02 Million). See how much does Arvee Laboratories (India) Limited reinvest in capital to understand how much of operating cash flow is reinvested back into capital assets.
Arvee Laboratories (India) Limited Market Cap History: 2018 to 2026
Arvee Laboratories (India) Limited's market capitalization history from 2018 to 2026. Data shows growth from $3.07 Million to $18.68 Million (21.05% CAGR).
Arvee Laboratories (India) Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Arvee Laboratories (India) Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.07x
Arvee Laboratories (India) Limited's market cap is 0.07 times its annual revenue
Latest Price to Earnings (P/E) Ratio
1.18x
Arvee Laboratories (India) Limited's market cap is 1.18 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $3.07 Million | $447.67 Million | $10.89 Million | 0.01x | 0.28x |
| 2019 | $3.19 Million | $539.54 Million | $22.63 Million | 0.01x | 0.14x |
| 2020 | $4.95 Million | $448.42 Million | $22.99 Million | 0.01x | 0.22x |
| 2021 | $9.92 Million | $471.44 Million | $26.77 Million | 0.02x | 0.37x |
| 2022 | $15.45 Million | $403.27 Million | $25.74 Million | 0.04x | 0.60x |
| 2023 | $20.61 Million | $612.76 Million | $41.19 Million | 0.03x | 0.50x |
| 2024 | $20.71 Million | $303.42 Million | $10.52 Million | 0.07x | 1.97x |
| 2025 | $25.42 Million | $384.87 Million | $21.47 Million | 0.07x | 1.18x |
Competitor Companies of ARVEE by Market Capitalization
Companies near Arvee Laboratories (India) Limited in the global market cap rankings as of August 4, 2026.
Key companies related to Arvee Laboratories (India) Limited by market ranking:
- Linde plc Ordinary Shares (NASDAQ:LIN): Ranked #93 globally with a market cap of $210.18 Billion USD.
- AIR LIQUIDE ADR 1/5/EO 11 (F:AILA): Ranked #235 globally with a market cap of $103.86 Billion USD ( €88.84 Billion EUR).
- Air Liquide SA (PA:AI): Ranked #251 globally with a market cap of $101.06 Billion USD ( €86.44 Billion EUR).
- Sherwin-Williams Co (NYSE:SHW): Ranked #310 globally with a market cap of $84.49 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #93 | Linde plc Ordinary Shares | NASDAQ:LIN | $210.18 Billion | $478.38 |
| #235 | AIR LIQUIDE ADR 1/5/EO 11 | F:AILA | $103.86 Billion | €36.60 |
| #251 | Air Liquide SA | PA:AI | $101.06 Billion | €170.72 |
| #310 | Sherwin-Williams Co | NYSE:SHW | $84.49 Billion | $340.85 |
Arvee Laboratories (India) Limited Historical Marketcap From 2018 to 2026
Between 2018 and today, Arvee Laboratories (India) Limited's market cap moved from $3.07 Million to $ 18.68 Million, with a yearly change of 21.05%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs18.68 Million | -26.54% |
| 2025 | Rs25.42 Million | +22.77% |
| 2024 | Rs20.71 Million | +0.47% |
| 2023 | Rs20.61 Million | +33.40% |
| 2022 | Rs15.45 Million | +55.83% |
| 2021 | Rs9.92 Million | +100.48% |
| 2020 | Rs4.95 Million | +55.14% |
| 2019 | Rs3.19 Million | +3.88% |
| 2018 | Rs3.07 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of Arvee Laboratories (India) Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $18.68 Million USD |
| MoneyControl | $18.68 Million USD |
| MarketWatch | $18.68 Million USD |
| marketcap.company | $18.68 Million USD |
| Reuters | $18.68 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Arvee Laboratories (India) Limited
Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroi… Read more